Mostrando 23,881 - 23,900 Resultados de 24,879 Para Buscar '".eu"', tiempo de consulta: 0.24s Limitar resultados
  1. 23881
    por Mitaroff, Angela
    Publicado 2001
    “…In the following it was also tested with an 241Am-Be source in the CERN calibration laboratory and at CERF (CERN-EU high-energy reference field). The CERF facility is very well characterized and provides a broad neutron field from thermal energies up to several hundreds of MeV with a large relative contribution of 10-100 MeV neutrons. …”
    Enlace del recurso
  2. 23882
    por Mayer, S
    Publicado 2003
    “…At CERN, an opportunity for such a reference field is realized by the CERF-field (CERN-EU high-energy reference field). The field provides a mixed field of mainly neutrons ranging from thermal energies up to hundreds of GeV accompanied by photons and muons. …”
    Enlace del recurso
  3. 23883
    “…TRIAL REGISTRATION: European Union Drug Regulating Authorities Clinical Trials Database (EuDRACT 2011—000608-16); ISRCTN (International Standard Randomised Controlled Trial Number (isrctn51772481).…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 23884
    “…The Mitigating the Health Effects of Desert Dust Storms Using Exposure-Reduction Approaches clinical randomised intervention study in adults with AF is funded by EU LIFE+programme to evaluate the efficacy of recommendations aiming to reduce exposure to desert dust and related heart arrhythmia effects. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 23885
    “…OBJECTIF: Le confinement en lien avec la pandémie de SARS-CoV-2 a eu des répercussions variées et inattendues sur les habitudes de vie des patients. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 23886
    “…Clinical trial registration EudraCT, eudract.ema.europa.eu, 2018-000129-29; ClinicalTrials.gov, NCT03535168 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-023-02384-8.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 23887
  8. 23888
    “…Undocumented migrants represent a large part of the population in Countries of the European Union (EU) such as Italy. Their health burden is not fully understood and likely to be related mainly to chronic conditions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 23889
    “…Atrial fibrillation (AF) is the commonest cardiac arrhythmia, affecting 3 million people in the USA and 8 million in the EU (according to the European Society of Cardiology). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 23890
    “…The 2015 Taiwan Color Dust Explosion burn mass casualty engendered the transfer of emergency tranches of skin allograft from reserves in both the US and EU to Taiwan. HHS/ASPR/BARDA/CBRN led an after-action fact-finding mission to Taiwan and concluded that skin allograft would still play a central role as a safety net in US national burn care preparedness, even as BARDA invested in the development of other burn medical countermeasures that would be part of the preparedness strategy. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 23891
    por Bardia, Aditya, Viale, Giuseppe
    Publicado 2023
    “…Recently reported results from the DESTINY-Breast04 trial demonstrated that the HER2-targeted antibody–drug conjugate trastuzumab deruxtecan (T-DXd) improved survival in patients with previously treated advanced or metastatic HER2-low breast cancer, leading to the approval of T-DXd in the US and EU for patients with unresectable or metastatic HER2-low breast cancer after prior chemotherapy in the metastatic setting or disease recurrence within 6 months of adjuvant chemotherapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 23892
    “…In the context of IC2PerMed, we implemented a survey to understand the state of the art of the implementation of PM related policies in EU and China, and to identify opportunities for future Sino-European collaborations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 23893
  14. 23894
    “…LX22NPO5104) — Funded by the European Union — Next Generation EU and a personal grant from the Dutch Heart Foundation (2021T016). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 23895
    “…FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – EU funding. Main funding source(s): CATCH ME: Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly BACKGROUND: We recently demonstrated that in human atria, endomysial fibrosis causes conduction disturbances during atrial fibrillation (AF), while overall connective tissue content (over-all fibrosis) has no effect. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 23896
    “…FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Horizon 2020 BACKGROUND: Sudden cardiac death (SCD) is a major public health issue in which most events occur in the general population. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 23897
    “…FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Nemzeti Kardiovaszkuláris Laboratórium RRF-2.3.1-21-2022-00003. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 23898
    “…LX22NPO5104) - Funded by the European Union – Next Generation EU, by the Ministry of Health of the Czech republic, grant number NU21-02-00584, and by the CAS project RVO:68081731. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 23899
    “…TRIAL REGISTRATIONS: The trial (IB1001-301) has been registered at www.clinicaltrials.gov (NCT05163288) and www.clinicaltrialsregister.eu (EudraCT: 2021–005356-10). Registered on 20 December 2021. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 23900
    “…We previously demonstrated safety, immunogenicity and preliminary evidence of clinical efficacy in stage III/IV resected melanoma patients subjected to a combination therapy based on peptide vaccination together with intermittent low-dose interferon-α2b, with or without dacarbazine preconditioning (https://www.clinicaltrialsregister.eu/ctr-search/search, identifier: 2008-008211-26). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS